About Robert Croce
Form D filings for Willow Innovations from 2015 to 2020 list Robert Croce as director.
Form D filings also name Robert Croce as a director at Earlens and Moximed.
Robert Croce first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Croce in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Croce works with at each company, as listed on that company's latest Form D.
Willow Innovations, Inc. · Form D, Oct 1, 2020
AC
Andrew Chmyz
Chief Financial Officer
IR
Ivy Ross
Director
NR
Nina Richardson
Director
SF
Stacy Feld
Director
JM
Joshua Makower
Director
LC
Laura Chambers
Executive officer and director
MC
Michael Carusi
Director
Earlens Corp · Form D, May 24, 2018
PL
Phil Lyons
Executive officer
JB
Judy Brimacombe
Executive officer
WF
William Facteau
President and CEO, director
YL
Yoh-Chie Lu
Director
TP
Thomas Prescott
Director
AT
Art Taylor
Director
MB
Mark Bishop
Executive officer
FT
Frank Torti
Director
GK
Greg Koskowich
Executive officer
BS
Bernard Shay
Executive officer
SE
Steven Elms
Director
HJ
Henry Plain, Jr.
Director
RD
Rodney Perkins, M.D.
Director
JJ
Jeff Jones
Executive officer
Moximed, Inc · Form D, Mar 31, 2017
AF
Arthur Franken
Director
RA
Robert Anderson
Director
DM
Dan Murray
Chief Financial Officer
HP
Henry Plain
Director
JM
Joshua Makower
Director
CS
Christopher Shen
Director
RD
Ryan Drant
Director
KS
Kevin Sidow
President/CEO and director